May 20, 2020 / 03:40PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Good morning. This is Dan Brennan. I cover tools and diagnostics and pharma services for UBS. And pleased to be joined here on day 3 of our virtual conference with Brad Gray, President and CEO of NanoString Technologies. Really glad to have Brad...
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
Glad to be here, Dan.
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
That's awesome, Brad. Thanks for being here. Sorry for the scratchy voice. I think it'll clear up in a moment. For those of you joining on the webcast, don't be shy, feel free to punch in some questions, and I'll see them pop up here on my screen. And I'll do my best, as I've tried to do throughout the other presentations, to get to it.
But listen, Brad and I go a ways back, and the company certainly had a very exciting
NanoString Technologies Inc at UBS Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot